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OBJECTIVE: This study investigated the effects of buflomedil and pentoxifylline, both of which are used in reconstructive sur-
gery of hamster skin flap microcirculation, and evaluated the skin flap survival rate by orthogonal polarization spectral imaging. 
METHOD: Twenty-four adult male Syrian golden hamsters were divided into three groups: a control (C, 0.1 ml 0.9% saline), 
buflomedil (B, 3 mg/kg/day), and pentoxifylline group (P, 14.5 mg/kg/day). Treatments administered intraperitoneally were initi-
ated 1 hour before skin flap preparation and continued for 7 days post-operatively at 12-hour intervals. Preparations (skin flaps) 
were divided into 12 fields, which were organized into six bands. Functional capillary density (FCD, in mm/mm2), distance from 
the skin flap base to blood flow cessation (Dist
with flow
, in cm), percentage of viable skin (VA, in%), and qualitative analysis of blood 
flow by orthogonal polarization spectral imaging were performed at 1 and 24 hours and on the seventh post-operative day. 
RESULT: Bands IV, V, and VI presented no flow independent of time. The functional capillary density group B was higher than 
that of groups C and P, primarily after 24 hours. All groups showed an increase in D with time but reached similar final distances 
(C = 2.73, B = 2.78 and P = 2.70 cm). Moreover, the percentage of viable areas remained at approximately 50%. The orthogonal 
polarization spectral imaging was useful to assess viability by counting fields with and without blood flow. 
CONCLUSIONS: Functional capillary density values were higher in the buflomedil group compared to the control and pentoxi-
fylline groups in this model. Functional capillary density did not influence D or the percentage of VA, and the technique showed 
favorable potential to assess/predict the viability of skin flaps within 1 h after surgery. 
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INTRODUCTION
Skin flap necrosis is a serious concern in reconstructive 
surgery. The surgical procedure used to create flaps involves 
tissue damage because some areas may exceed the territory 
supplied by a given blood vessel, leading to several degrees 
of ischemia.1 Moreover, microvascular perfusion is seriously 
impaired with failing procedures.2,3 Vasoactive drugs can be 
used to ameliorate the ischemia process and extend survival. 
Buflomedil and pentoxifylline have often been used in the 
treatment of peripheral artery disease and microcirculatory 
deficit, resulting in improved flap viability.4-7
Buflomedil is an alpha-receptor blocking agent and a 
non-specific calcium antagonist. It can also inhibit platelet 
aggregation, increase red blood cell deformability, and 
decrease peripheral vascular resistance, thus restoring 
microcirculatory perfusion.8 Buflomedil appears to improve 
nutritional blood flow in ischemic tissue in peripheral 
or cerebral diseases. Consequently, it increases walking 
distances in patients suffering from intermittent claudication.9
Pentoxifylline is a xanthine-derived phosphodiesterase 
inhibitor that enhances cAMP levels, theoretically via the 
same actions as buflomedil,10 i.e., it has beneficial effects on 
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white blood cell function and hemorheological conditions.11
The effects of buflomedil and pentoxifylline administration 
on functional capillary density, tissue viability based on blood 
flow presence/absence, and survival of skin flaps in hamsters 
have yet to be elucidated.Skin flap microcirculation can be 
evaluated by orthogonal polarization spectral (OPS) imaging. 
This recently developed microscopy method, originally 
described by Winkelman,12 can be used to non-invasively 
study the microcirculation with reflected light without any 
fluorescent dye.13 Olivier and co-workers showed that OPS 
technology is useful to directly observe microvascular blood 
flow in skin flaps and suggested post-operative monitoring 
of free-tissue transfers.14 The OPS technique has been 
incorporated into a portable device, the Cytoscan (Cytoscan, 
Cytometrics Inc., Philadelphia, PA, USA). 
This study tested the efficiency of OPS imaging for 
the prognosis of flap viability, and compared the effects of 
acutely administered buflomedil and pentoxifylline on the 
microcirculation using a random-pattern skin flap survival 
test.
MATERIALS AND METHODS
Experiments were performed according to the protocols 
approved by the Ethical Committee of the State University 
of Rio de Janeiro, RJ, Brazil (CEA/215/2007) using 24 
male 10-week-old Syrian golden hamsters (Mesocricetus 
auratus, Botucatu, São Paulo, SP, Brazil) weighing 110-130 
g. Hamsters were divided into three groups. The control 
group received 0.1 ml of vehicle (C, 0.9% NaCl), the 
buflomedil (B) group received 3 mg/kg/day of buflomedil 
(Abbott, São Paulo, Brazil), and the pentoxifylline (P)
group received 14.5 mg/kg/day of pentoxifylline (Aventis 
Pharma, São Paulo, Brazil). All injections were administered 
intraperitoneally 1 hour before skin flap preparation and 
for 7 days post-operatively at 12-hour intervals. Animals 
received an appropriate laboratory diet of Nuvital (Nuvilab, 
Curitiba, PR, Brazil) and water provided ad libitum.
Animals were anesthetized with 30 mg/kg of sodium 
pentobarbital (Pentobarbital sodique, Sanofi, Paris, France, 
60 mg/ml) intraperitoneally. Throughout the surgery and 
subsequent experiment, the temperature of the animals was 
maintained at 36.5 °C with a heating pad controlled by a 
rectal thermistor (LTB 750 Thermostat System, Uppsala, 
Sweden). A dorsal tricotomy was performed, followed 
by local antisepsia with 70% alcohol. The dorsal flap was 
dissected, preserving the sacral arteries, and detached from 
its panniculus carnosus. The area was subsequently sutured 
to the dorsal region of the animal using simple stitches. 
The surgical protocol was based on the McFarlane skin flap 
model (Olivier et al.)14,15 adapted to hamsters.
OPS imaging Protocol
Each dorsal randomized skin flap measured 2 x 6 
cm and was divided into 12 fields of 1 cm in diameter. 
Each of the two fields formed one band to be analyzed 
(Figure 1). An OPS probe, with a 10x objective and a final 
magnification of 450x, was applied to these fields from the 
base of the flap to the apex (Figure 1). The center of each 
field had a microscopic area of 700x550 µm. Images of the 
microcirculation were video recorded, stored in VHS format, 
and subsequently processed by CapImage.16 Sterile mineral 
oil was applied between the probe and skin to improve the 
coupling and reliability of the readings.
Parameters Evaluated
Functional Capillary Density (FCD)
Functional capillary density (FCD) was defined as the 
total length of capillaries with flowing red blood cells in the 
microscopic area (mm/mm2) under observation. This was 
measured at 1 and 24 hours after the surgical procedure. The 
mean values of the fields from each band are reported.
Distance from the skin flap base to blood flow cessation 
(Dist
with flow
)
The distance from the skin flap base to the blood flow 
cessation (Dist
with flow
) field was measured at 1 h, 24 h, and 7 
days after surgery and compared to viable skin flaps. 
Percentage of viable skin flap area (%VA)
A transparent sheet was placed on the dorsal skin flap 
and drawings of the areas with blood flow and necrosis 
were performed. The percentage of viable area (%VA) 
was calculated by dividing the healthy area by the total 
area on the seventh post-operative day using Autocad 2000 
(Autodesk, San Rafael, USA) (Figure 2). 
Figure 1 - Hamster skin flap model. Left side: the Cytoscan probe fixed by 
a mechanical device on the dorsal part of the animal. Right side: division of 
the skin flap into 12 fields from the caudal to cranial regions.
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Qualitative analysis of blood flow by OPS imaging
The presence or absence of blood flow in the studied skin 
flaps was quantified in all 12 fields, grouped in bands (Figure 
1) after 1 and 24 h. The mean values of the fields from each 
band are reported. The data obtained were compared to the 
blood flow in the viable area observed on the seventh post-
operative day. 
Statistical Analyses
For clarity, the results are presented as the mean ± 
standard error of the mean (S.E.M.). For statistical analysis, 
Mann-Whitney U tests, ANOVAs, and Wilcoxon matched 
pair tests were used to compare groups, and P-values < 0.05 
were considered as statistically significant. 
RESULTS
All animals investigated did not demonstrate blood flow 
after the third band of the skin flap, independent of the post-
operative time. 
Figure 3 shows the FCD for the control, buflomedil, 
and pentoxifylline groups on bands I, II, and III 1 and 24 
hours after the surgical procedure. A decrease in FCD was 
observed from band I to band III in all groups analyzed after 
24 hours. The buflomedil group showed higher FCD values 
compared to the control or pentoxifylline group for each 
band at 1 and 24 h. Conversely, no statistical differences 
were observed for Dist
with flow
 between the control, buflomedil, 
and pentoxifylline groups. 
Although all groups displayed increased distances 
between 24 h and the seventh day, they reached similar final 
distances (control = 2.73 cm, buflomedil = 2.78 cm, and 
pentoxifylline = 2.70 cm) (Figure 4). 
The percentage of viable area is illustrated in Figure 5. 
The perfusion/non-perfusion interface was easily identified, 
Figure 2 - Dorsal skin flap of the hamster on the seventh post-operative 
day. The percentage of viable area was obtained by dividing the healthy 
area by the total area
Figure 3 - The functional capillary density on bands I, II, and III among the 
control (C), Buflomedil (B), and Pentoxifylline (P) groups. These groups 
were evaluated 1 and 24 h after skin flap preparation. *p < 0.05 compared 
to controls
Figure 5 - Viable skin flap area on the seventh post-operative day
Figure 4 - Distance from the skin flap base to blood flow cessation in the 
control, Buflomedil, and Pentoxifylline groups. These groups were evaluated 
1 (Time 1h) and 24 (Time 24h) hours and 7 (Time 7d) days after skin flap 
preparation. *,# p < 0.05 compared to Time 1h
800
CLINICS 2009;64(8):797-802Pentoxifylline and buflomedil on microcirculation
Coelho da Mota DS et al.
and there was no difference in the percentage of viable 
areas among the control, buflomedil, and pentoxifylline 
groups (50.7, 52.9, and 47.0, respectively). Finally, the mean 
percentage of the preserved area was approximately 50% for 
all groups. 
On the seventh post-operative day, we were able to 
confirm the presence of blood flow, which was detected after 
1 h using OPS imaging of the first three bands for all groups. 
Using this technique, however, we were unable to correlate 
all areas that lacked blood flow with a given time line. For 
band II, an area of 100% in the control, buflomedil, and 
pentoxifylline groups without blood flow 1 h after surgery 
developed into perfused zones 7 days after surgery. The 
prediction of blood flow absence (in %) after 1 h and on post-
operative day 7 for the control, buflomedil, and pentoxifylline 
groups for band III is shown in Figure 6. Note that the 
percentage of fields without blood flow detected by Cytoscan 
in controls decreased from 75% after 1 h to 60% after 7 days. 
This corresponds to a prediction power of 80%. The same 
pattern occurred for the buflomedil and pentoxifylline groups. 
DISCUSSION
When a skin flap is raised, injury to the blood vessels 
and sympathetic nerves causes hemodynamic instability, 
leading to blood flow abnormality and a disturbance in 
tissue oxygenation.17 In this work, two approaches were 
used to evaluate skin flap success. We used buflomedil 
and pentoxifylline and determined their effects on the 
microcirculation and skin flap survival (FCD, Dist
with flow
,
%VA), and the OPS imaging technique to predict flap 
viability over time following surgery. 
Since significant microvascular damage is present during 
skin flap preparation, the development of early necrotic 
areas is expected. Indeed, all fields on bands IV, V, and VI 
did not present any blood flow, resulting in tissue death. 
The FCD decreased in all groups from band I to band III 
and was significantly lower on the distal part of the flap 
compared to its base after 24 h. The buflomedil group 
demonstrated higher values of FCD compared to the control 
and pentoxifylline groups. These results are consistent with 
the results reported by Langer and colleagues, who validated 
the use of OPS imaging against intravital microscopy and 
measured FCD on the skin flaps of hairless mice.18 Harder 
et al. also showed a decrement in FCD in several segments 
from the base to the apex of the skin flaps of mice.19
Buflomedil has been shown to have positive effects on 
microvascular reperfusion injury by decreasing leukocyte 
adhesion.20 However, Szczesny et al. showed that buflomedil 
is ineffective in avoiding a decrease in the FCD of local skin 
blood perfusion during general anesthesia using intravital 
fluorescence microscopy in hairless mice.21 In addition, 
resting skin flux motion activity at the hallux in patients 
with intermittent claudication evaluated by laser Doppler 
fluxometry was not increased after buflomedil treatment.22
It is possible that the results presented herein could be 
explained by better buflomedil effects on the redistribution 
of blood flow after ischemia compared to pentoxifylline. 
In fact, Briguglio et al. demonstrated an attenuation of 
ischemia-induced histological loss and damage to pyramidal 
cells in rats treated with buflomedil.23 On the other hand, 
FDC showed favorable results and Dist
with flow
 did not change 
among the control, buflomedil, and pentoxifylline groups 
at any time point analyzed. For each group, increasing 
values of Dist
with flow 
were detected from 1 hour to 7 days. 
Conflicting results have been reported concerning the actions 
of buflomedil and pentoxifylline on surface length necrosis 
on flaps or microcirculation. Quirinia and colleagues did 
not find any differences in wound healing for buflomedil 
compared to the control (no treatment) in rats24; however, 
Kamler and et al. showed an acceleration of wound surface 
area reduction after chronic ischemia.25 On the other hand, 
pentoxifylline elicited improved cardiovascular autonomic 
function, but failed to reduce microalbuminuria in type 2 
diabetic patients, revealing a microcirculatory defect.26
The percentage of viable area on the seventh day after the 
surgical procedure did not differ among the groups studied 
and remained at approximately 50%, consistent with the 
buflomedil results described by Biondo-Simões et al.27 This 
result could be explained by the following scenarios. The 
treatment duration was not sufficient to produce favorable 
blood flow redistribution (treatment was initiated 1 h before 
surgery and lasted 7 days), allowing only acute effects to be 
detected. Bayat and colleagues chronically pretreated rats 
for 30 days with pentoxifylline before skin flap preparation 
Figure 6 - Prediction by OPS imaging of the percentage of fields without 
blood flow after 1 h that persisted 7 days later
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and observed an increase in flap survival.28 Emrecan et al. 
showed that pentoxifylline could have an acute effect on 
the skeletal muscle of rabbits in an ischemia-reperfusion 
model.29 Our group selected buflomedil (3 mg/kg/day) and 
pentoxifylline (14.5 mg/kg/day) administration for 7 days 
post-surgery to elucidate the acute drug effects. 
Another possibili ty could be that buflomedil 
and pentoxifylline are not capable of improving the 
microcirculation without any previous impairment of this 
structure. A lower percentage of viable skin flap areas in 
pretreated rats has been demonstrated with nicotine, which 
decreases blood flow to peripheral vessels by 40%. The 
percentage of viable areas was larger for the buflomedil and 
pentoxifylline groups than for rats administered nicotine.30
Finally, severe impairment of the microcirculatory network 
during the surgical procedure might interfere with drug 
action. It is well known that thin skin flaps may jeopardize 
the circulation.31 In the present study, the dorsal skin flap 
and sacral arteries containing the panniculus carnosus
were preserved. It is likely, however, that some degree of 
arteriovenous shunting occurred over 24 h in the early and/or 
late post-operative periods, thereby limiting the skin survival 
in areas with marginal blood flow.32 Using a pig skin flap 
model, Kerrigan et al. observed that the dermal vessels of 
an ischemic island flap were dramatically affected.3 We also 
observed several distal random ischemic regions, which may 
have determined the final survival of the flap. 
The Cytoscan was very effective in predicting skin flap 
viability. All fields in which blood flow was present after 
1 and 24 h (detected by Cytoscan) remained viable 7 days 
after surgery. 
Conversely, the prediction rate for fields without blood 
flow was not as effective. All fields without blood flow 
on band II and 20% of the fields on band III in all groups 
recovered after 7 days. Thus, the Cytoscan was more 
efficient in predicting fields without blood flow on band 
III, which had direct contact with the necrotic area and was 
subjected to unstable hemodynamics. It must be noted that 
some fields with unpredictable blood flow recovery will 
normally be present,33,34 and it should be emphasized that 
the OPS technique appeared to be more accurate than the 
clinical evaluation of skin flap necrosis.14 Other evaluations 
of microcirculation techniques also exist, such as intravital 
fluorescence microscopy,35 but the portability of this 
technique is limited. Laser Doppler flowmetry36 also appears 
to be a promising technique for use with OPS imaging. 
CONCLUSIONS
Buflomedil presented higher values of FCD compared 
to the control and pentoxifylline groups in the skin flap 
hamster model. However, no differences were observed for 
the distance from the skin flap base to blood flow cessation 
or the percentage of viable skin flaps among groups. 
Orthogonal polarization spectral imaging is a very useful 
tool to assess skin flap viability by counting fields with and 
without blood flow, showing the ability to confirm 100% of 
the areas with and 80% of the areas without flow over time. 
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